Correlation Between Qingdao NovelBeam and Jafron Biomedical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Qingdao NovelBeam and Jafron Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qingdao NovelBeam and Jafron Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Qingdao NovelBeam Technology and Jafron Biomedical Co, you can compare the effects of market volatilities on Qingdao NovelBeam and Jafron Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qingdao NovelBeam with a short position of Jafron Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qingdao NovelBeam and Jafron Biomedical.

Diversification Opportunities for Qingdao NovelBeam and Jafron Biomedical

0.91
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Qingdao and Jafron is 0.91. Overlapping area represents the amount of risk that can be diversified away by holding Qingdao NovelBeam Technology and Jafron Biomedical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jafron Biomedical and Qingdao NovelBeam is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qingdao NovelBeam Technology are associated (or correlated) with Jafron Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jafron Biomedical has no effect on the direction of Qingdao NovelBeam i.e., Qingdao NovelBeam and Jafron Biomedical go up and down completely randomly.

Pair Corralation between Qingdao NovelBeam and Jafron Biomedical

Assuming the 90 days trading horizon Qingdao NovelBeam Technology is expected to under-perform the Jafron Biomedical. In addition to that, Qingdao NovelBeam is 1.09 times more volatile than Jafron Biomedical Co. It trades about -0.07 of its total potential returns per unit of risk. Jafron Biomedical Co is currently generating about -0.03 per unit of volatility. If you would invest  3,112  in Jafron Biomedical Co on September 1, 2024 and sell it today you would lose (64.00) from holding Jafron Biomedical Co or give up 2.06% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy95.65%
ValuesDaily Returns

Qingdao NovelBeam Technology  vs.  Jafron Biomedical Co

 Performance 
       Timeline  
Qingdao NovelBeam 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Qingdao NovelBeam Technology are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Qingdao NovelBeam sustained solid returns over the last few months and may actually be approaching a breakup point.
Jafron Biomedical 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Jafron Biomedical Co are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Jafron Biomedical sustained solid returns over the last few months and may actually be approaching a breakup point.

Qingdao NovelBeam and Jafron Biomedical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Qingdao NovelBeam and Jafron Biomedical

The main advantage of trading using opposite Qingdao NovelBeam and Jafron Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qingdao NovelBeam position performs unexpectedly, Jafron Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jafron Biomedical will offset losses from the drop in Jafron Biomedical's long position.
The idea behind Qingdao NovelBeam Technology and Jafron Biomedical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.